Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on NasdaqPR Newswire•06/08/2026•06:24 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?